hVIVO | Sustainability Performance
Engaged in the clinical research and development sector, focusing on human challenge studies and viral infections. The company aims to support the pharmaceutical industry in developing vaccines and antiviral therapies through innovative clinical trial solutions.
2011
United Kingdom
201 - 500 employees
Biotechnology
$25M - 100M in revenue
$10M - 25M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4111
Overallⓘ#542
in United Kingdomⓘ#80
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
- hVIVO's human challenge trial model intentionally infects healthy volunteers with pathogens, raising bioethics considerations.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.